Enovix (NASDAQ:ENVX) Issues Q2 2026 Earnings Guidance

Enovix (NASDAQ:ENVX) issued an update on its second quarter 2026 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of -0.170–0.130 for the period, compared to the consensus estimate of -0.160. The company issued revenue guidance of $8.0 million-$9.0 million, compared to the consensus revenue estimate of $8.5 million.

Analysts Set New Price Targets

A number of research firms have weighed in on ENVX. Craig Hallum dropped their price target on Enovix from $16.00 to $10.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Wells Fargo & Company set a $6.00 target price on Enovix in a report on Thursday, March 12th. Canaccord Genuity Group cut their price target on shares of Enovix from $21.00 to $15.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. JPMorgan Chase & Co. cut shares of Enovix from a “neutral” rating to an “underweight” rating in a research report on Wednesday, May 6th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Enovix in a research note on Friday, April 10th. Six research analysts have rated the stock with a Buy rating, two have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, Enovix currently has a consensus rating of “Hold” and an average target price of $14.05.

Enovix Stock Up 4.6%

ENVX stock traded up $0.32 during mid-day trading on Wednesday, hitting $7.29. 11,756,075 shares of the company were exchanged, compared to its average volume of 6,191,556. The company has a market capitalization of $1.59 billion, a PE ratio of -9.47 and a beta of 2.24. The firm has a fifty day simple moving average of $5.74 and a 200 day simple moving average of $7.18. The company has a current ratio of 8.34, a quick ratio of 8.13 and a debt-to-equity ratio of 1.90. Enovix has a twelve month low of $4.61 and a twelve month high of $16.49.

Enovix (NASDAQ:ENVX) last released its quarterly earnings data on Wednesday, May 13th. The company reported ($0.14) EPS for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.01. Enovix had a negative net margin of 492.57% and a negative return on equity of 64.29%. The firm had revenue of $7.60 million during the quarter, compared to the consensus estimate of $6.95 million. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. On average, research analysts forecast that Enovix will post -0.81 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Enovix

Hedge funds have recently made changes to their positions in the business. CIBC Bancorp USA Inc. bought a new stake in shares of Enovix during the 3rd quarter worth about $175,000. Focus Partners Wealth bought a new position in shares of Enovix in the third quarter valued at approximately $170,000. MML Investors Services LLC increased its stake in shares of Enovix by 12.1% during the fourth quarter. MML Investors Services LLC now owns 20,987 shares of the company’s stock valued at $153,000 after acquiring an additional 2,268 shares during the period. Equitable Holdings Inc. increased its stake in shares of Enovix by 10.9% during the third quarter. Equitable Holdings Inc. now owns 13,700 shares of the company’s stock valued at $137,000 after acquiring an additional 1,342 shares during the period. Finally, Headlands Technologies LLC bought a new stake in Enovix during the second quarter worth approximately $132,000. Institutional investors own 50.92% of the company’s stock.

About Enovix

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.